The QualityStocks Daily Monday, December 9th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (THOR) +170.52%

MarketClub Analysis (FTSV) +110.73%

Schaeffer's (ARQL) +103.88%

The QualityStocks Daily Stock List

Balmoral Resources Ltd. (BALMF)

Proactive Investors, OTC Markets, GlobeNewswire, Northern Miner, Metals News, Investing.com, Mining Feeds, InvestorsHub, Market Screener, Junior Mining Network, News Scanner, Mining.com, Resource World, Mining Atlas, Stockhouse, Trading View, Wallet Investor, and Streetwise Reports reported earlier on Balmoral Resources Ltd. (BALMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Balmoral Resources Ltd. is an exploration company exploring a portfolio of gold and base metal properties positioned within the prolific Abitibi greenstone belt. The Company’s flagship, 1,000 km2 Detour Gold Trend Project hosts the resource-stage Bug and Martiniere West gold deposits and the Grasset nickel-copper-cobalt-PGE deposit. Balmoral is led by an experienced and successful Board of Directors and Management team with a lengthy track record of creating shareholder value through the exploration process. Balmoral Resources is headquartered in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Balmoral Resources has dual exposure to the gold and nickel sulphide markets. Its gold projects consist of Martiniere, Northshore, N2, Lynx-Rambo, Lac Du Doight, Grasset Gold, Area 52 (Fenelon), Detour Trend, and Vortex Ext. Its nickel projects consist of Grasset, GUC Central, Gargoyle, RUM, Goblin, and Ghost.

Grasset is a Nickel-Copper-Cobalt- PGE Deposit. It is the most advanced of the nickel discoveries made by the Company in the Grasset Ultramafic Complex. The Project is 100 percent owned by Balmoral Resources - royalty free. 2018 drilling extended the H1 Zone of the deposit to 800 vertical meters (an increase of over 300 meters) and planned winter 2020 drilling is targeting the H3 Zone to a similar depth.

The Grasset Nickel Deposit features some of the highest tenor (nickel content) sulphides in Canada. This allows it to produce extremely high nickel grades. Balmoral previously announced additional discoveries within the Grasset Ultramafic Complex 7 km to the NW. At the Grasset Nickel Deposit, nickel, copper, cobalt, platinum and palladium are all considered recoverable and payable.

Last week, Balmoral Resources announced the successful expansion of the recently discovered, near-surface high-grade Ripley Gold Zone within the Area 51 gold system on its Fenelon Property in Quebec. The Fenelon Property forms part of Balmoral’s district-scale Detour Gold Trend Project in Quebec. The Company’s Detour Gold Trend Project adjoins the holdings of Detour Gold Corp. on its western end, surrounds and controls a portion of the fast expanding Area 51 gold system, , and features Balmoral’s wholly-owned Martiniere gold and Grasset nickel deposits.

All nine holes completed during the second phase of drilling in Area 52 targeted the Ripley Zone that was first intersected in drilling earlier this summer. The Ripley Zone is one of three zones of significant gold mineralization intersected in Area 52 that is situated immediately south and along trend from Wallbridge Mining’s Area 51 gold discovery.

Gold grades in individual intercepts from the present program range from 0.12 g/t gold over 2.60 meters to a high of 32.70 g/t gold over 0.39 meters. Locally the gold mineralized zone reaches widths of more than 22 meters. Higher grade, visible gold-bearing intervals in discovery hole A52-19-03, and holes A52-19-05, A52-19-08, A52-19-09 and A52-19-13 indicate a steep west-southwest plunge for the high-grade gold mineralization at Ripley.

Balmoral Resources Ltd. (BALMF), closed Monday's trading session at $0.2634, up 14.5217%, on 436,450 volume with 108 trades. The average volume for the last 3 months is 149,506 and the stock's 52-week low/high is $0.065700002/$0.287999987.

chart

Bitfarms Ltd. (BFARF)

TipRanks, Macroaxis, Metals Channel, Market Screener, Morningstar, GuruFocus, TradingView, MarketWatch, Market News Video, OTC Markets, Dividend.com, Dividend Investor, and Stockhouse reported earlier on Bitfarms Ltd. (BFARF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bitfarms Ltd. owns and operates computing centers that power the international decentralized financial economy. The Company provides computing power to cryptocurrency networks including Bitcoin, earning fees from each network for securing and processing transactions. Bitfarms operates 5 computing centers in the Province of Québec. These are powered by clean and competitively priced hydroelectricity. The Company operates one of the largest cryptocurrency mining operations in North America. Bitfarms has its corporate office in Toronto, Ontario and its operations office in Brossard, Québec.

The Company’s experienced management team includes industrial-scale data center operators and capital markets professionals. They are centered on building infrastructure for the future through developing and hosting the ecosystem growing around blockchain-based technologies.

Regarding power use efficiency, 96 percent of all electricity consumed by Bitfarms in Q3 2019 was used for computing power. Its farms are powered by competitively priced, green hydroelectricity. The Company’s energy portfolio comprises 159.5 megawatts. At present, Bitfarms is building out Phase 1 and 2 of its new computing centre in Sherbrooke, Québec.

The Company’s data centers are designed, constructed and operated in-house with no reliance or third-party services. The Company continues to realize strong returns on invested capital through a focus on industrial-scale operational efficiencies, and cost-effective infrastructure build-out via its 100 percent owned electrical contractor, Volta Electrique. Bitfarms features 100 percent owned electrical contractors - on-staff electricians provide cost-effective and timely buildouts.

Recently, Bitfarms announced its consolidated results for the three and nine months ended September 30, 2019. Selected highlights include Consolidated Revenue of US$9.7 million; Gross Profit of US$4.5 million (46 percent Gross Profit Margin), Operating Income of US$2.1 million (22 percent operating margin), and Net Income of US$4.3 million.

Bitfarms mined 834 Bitcoin and 1,219 Litecoin in Q3 2019. The Company completed the acquisition of 7,795 new generation ASICs of which 4,750 of the acquired ASICS were installed as at September 30, 2019. The 4,750 installed ASICs produce about 240 PH/s of hashrate and represent an increase of roughly 79 percent since the end of Q2 2019.

Bitfarms Ltd. (BFARF), closed Monday's trading session at $0.42651, up 2.1581%, on 2,600 volume with 2 trades. The average volume for the last 3 months is 2,578 and the stock's 52-week low/high is $0.000099999/$3.00.

chart

Blueberries Medical Corp. (BBRRF)

Small Cap Power, NIC Investors, Technical420, Dividend Investor, Stockhouse, Financial Buzz, InvestorsHub, Street Insider, PR Newswire, Profit Confidential, Midas Letter, InvestorX, Morningstar, Market Screener, Stockwatch, GlobeNewswire, Wallet Investor, Nasdaq, Investing.com, and TradingView reported beforehand on Blueberries Medical Corp. (BBRRF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Blueberries Medical Corp. is a Latin American licensed producer of medicinal cannabis and cannabis-derived products. The Company is a producer of naturally grown premium quality cannabis with its principal operations ideally located in the Bogotá Savannah of central Colombia and operations presently being established in Argentina. In Argentina, Blueberries Medical is advancing a pilot project in a joint venture (JV) with the state-owned company Cannava. Blueberries Medical is headquartered in Bogotá, Colombia.

A specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing leads the Company. Blueberries Medical is fully licensed for the cultivation, production, domestic distribution, and global export of CBD (cannabidiol) and THC-based (tetrahydrocannabinol) medical cannabis in Colombia. Blueberries Medical’s combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned it to become a foremost international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

The Company has a large cultivation footprint with scalable growing capacity through contract growers. It has 142 exclusive Colombian cannabis strains with high CBD and THC contents. In addition, it has strong global partnerships for product development and distribution.

Concerning cannabis oil extracts, the Company develops high-end medicinal products for the treatment of manifold human conditions. It works together with small producers in the region of the Bogota Savanna and supplies medicinal cannabis products to the national and worldwide market.

Last week, Blueberries Medical announced that it began harvest of its first commercial crops at its 3.2-hectare Guatavita facility in Bogotá Savannah, Colombia. The crops comprise the Company’s five registered non-psychoactive CBD strains recently approved by the Colombian Institute of Agriculture (ICA), as announced on September 27, 2019. The five proprietary cultivars were developed and tested by Blueberries’ agronomy team and optimized for growth in the local climate and also maximized active ingredient yield.

One hundred (100) kg of dry flower have been harvested to date (as of December 3, 2019) with growth cycle time and yields in line with expectations. An additional 3,400 plants are in in the process of being harvested that will include approved cultivars and trial crops. The harvesting is scheduled to be completed by the end of this year with an expected yield of 400 to 500 kg of dry flower. Moreover, the expectation is that commercial production of CBD oil will commence in Q1 of 2020.

Blueberries Medical Corp. (BBRRF), closed Monday's trading session at $0.0641, off by 11.5862%, on 45,819 volume with 18 trades. The average volume for the last 3 months is 49,414 and the stock's 52-week low/high is $0.029999999/$0.649999976.

chart

Entrée Resources Ltd. (ERLFF)

Zacks, Market Chameleon, Investors Observer, MacroTrends, OTC Markets, Metals News, Equities, PR Newswire, Stockwatch, Investing News, Baystreet.ca, Investors Hangout, TeleTrader, Market Screener, Stockhouse, Dividend Investor, GuruFocus, Ceo.ca, Wallet Investor, TradingView, Investing.com and MarketWatch reported beforehand on Entrée Resources Ltd. (ERLFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Entrée Resources Ltd. owns a unique carried joint venture (JV) interest on a significant portion of one of the world’s largest copper-gold projects – the Oyu Tolgoi project in Mongolia. Its interest in the Entrée/Oyu Tolgoi JV has the characteristics of a royalty, with the benefits of a producer. The Company previously went by the name Entrée Gold, Inc. It changed its name to Entrée Resources Ltd. in May of 2017. Established in 1995, the Company is based in Vancouver, British Columbia. Entrée Resources lists on the OTCQB.

The Company has a 20 percent or 30 percent carried participating interest in the Entrée/Oyu Tolgoi JV, depending on the depth of mineralization. Sandstorm Gold Ltd., Rio Tinto and Turquoise Hill are major shareholders of Entrée Resources, holding roughly 19 percent, 9 percent and 8 percent of the shares of the Company, respectively.

The Entrée/Oyu Tolgoi JV Property includes the Hugo North Extension copper-gold deposit (HNE) and the majority of the Heruga copper-gold-molybdenum deposit. The resources at HNE include a Probable reserve that is part of the first lift (Lift 1) of the Oyu Tolgoi underground block cave mining operation. At present, Lift 1 is in development by project operator Rio Tinto.

Oyu Tolgoi LLC (OTLLC) carries almost all of the financial burden and execution risk on the Oyu Tolgoi underground project. This includes the Entrée/Oyu Tolgoi JV property. OTLLC finances Entrée Resources’ share of project/exploration costs at prime+2 percent, with Entrée to repay from 90 percent of free cash flow and no upfront cash is required from Entrée Resources.

Entrée Resources is not responsible for the upfront development capital of Oyu Tolgoi surface infrastructure or underground development on the Oyu Tolgoi mining licence.

Last month, Entrée Resources announced that Turquoise Hill Resources Ltd. provided an update on November 4, 2019 that the construction of Shaft 2 on the Oyu Tolgoi underground project is complete and is in the final stages of commissioning. Shaft 2 is a 10 meter diameter shaft that is sunk roughly 1.3 kilometers below the surface. The completion of Shaft 2 is a major milestone attained, as it will allow for up to 300 people in the service hoist and lift up to 60 tonne skips in the production hoist, both of which will speed up the development of the underground Oyu Tolgoi copper-gold mine.

Entrée Resources Ltd. (ERLFF), closed Monday's trading session at $0.29, even for the day, on 16,807 volume with 26 trades. The average volume for the last 3 months is 80,628 and the stock's 52-week low/high is $0.045099999/$0.460000008.

chart

Notox Technologies Corp. (NTOX)

Street Insider, wallstreet:online, Penny Stock Hub, Last10k, Stock Target Advisor, Simply Wall St, PredictWallStreet, Market Exclusive, Stockopedia, Investors Hangout, Wallet Investor, Market Screener, Stockwatch, TradingView, and Stockhouse reported earlier on Notox Technologies Corp. (NTOX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Notox Technologies Corp. concentrates on developing and commercializing inventive technologies. The Company is doing so chiefly via its wholly-owned Nevada subsidiary Notox Bioscience, Inc. Notox is working to market a credible, non-toxic alternative to Botox and subsequently develop other features of its Notox technology. This includes drug-free pain management, body countering, skin tightening as well as anti-perspiration. OTCQB-listed, Notox Technologies is based in Richmond Hill, Ontario.

Over the past two years, the Company has transitioned into developing, commercializing and promoting its patented Notox aesthetic and drug-free pain management platform. This is following its acquisition of the associated intellectual property (IP) rights in 2016. That patented IP was originally developed by Dr. Frank Papay, MD FACS Chairman Dermatology and Plastic Surgery Institute, Cleveland Clinic, and is owned by The Cleveland Clinic Foundation.

Notox Technologies is also working to build its distribution capabilities for other medical and aesthetic products globally. In February 2019, Notox announced that it entered into a relationship with the Veterans Global Initiative Foundation. This relationship to raise capital for the testing, development, and commercialization of Notox’s drug-free pain management solutions is primarily for the benefit of military veterans who suffer from pain. Notox Technologies and the VGI Foundation are working together to provide the Notox treatment either at no cost or at deeply discounted rates to those veterans who need relief the most and continue to suffer in cases where other treatments have not worked.

Last week, Notox Technologies announced that it completed the earlier-disclosed acquisition transaction with Xthetica, Inc., a private Canadian aesthetic and medical beauty distributor, and Mr. Manny Kapur, Xthetica's sole shareholder. On December 1, 2019, Notox, Xthetica, Inc., a private Nevada corporation of which Mr. Kapur is also the sole shareholder (Xthetica NV), and Mr. Kapur entered into a binding option and put agreement pursuant to which Notox, via a newly-created subsidiary entity named Xthetica Canada, Inc., acquired certain of Xthetica's assets. The assets include Xthetica's rights and obligations under a series of existing and future license and distribution agreements with manufacturers of aesthetic and medical beauty products, all of Xthetica's inventory, certain of Xthetica's goodwill and access to Xthetica's salesforce and expertise.

Notox Technologies Corp. (NTOX), closed Monday's trading session at $3.59, even for the day, on 16,807 volume. The average volume for the last 3 months is 6 and the stock's 52-week low/high is $1.80009996/$4.50.

chart

NutraLife BioSciences, Inc. (NLBS)

Financial Buzz, TipRanks, Financial Insiders, Investors Observer, New Media Wire, EIN Presswire, Stockopedia, Super Stock Screener, TradingView, Morningstar, last10k, Simply Wall St, Seeking Alpha, Investors Hangout, MarketWatch, InvestorsHub, Market Screener, TMXmoney, Wallet Investor, and GlobeNewswire reported beforehand on NutraLife BioSciences, Inc. (NLBS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

NutraLife BioSciences, Inc. operates a multifaceted life sciences company. In 2010, the Company formed to manufacture and distribute private label and branded nutraceutical and wellness products. In 2017, it launched its hemp-based PCR products. The Company previously went by the name NutraFuels, Inc. It changed its name to NutraLife BioSciences, Inc. in March of this year. NutraLife BioSciences has its head office in Coconut Creek, Florida.

By way of its subsidiaries, Precision Analytic Testing, Inc., and PhytoChem Technologies, Inc., NutraLife BioSciences provides bulk material analytical, identity, potency and purity testing of raw hemp, hemp cultivation, raw bulk material extraction, and processing. The Company’s commitment is to bringing high quality, effective, beneficial nutrients to market.

NutraLife BioSciences was founded by Mr. Edgar Ward, its Chief Executive Officer, President and Director, to engage in the development, manufacturing and distribution of innovative and effective nutritional products. Since then, the Company has developed into a successful developer, manufacturer and distributor of over 50 nutraceutical, wellness, and CBD (cannabidiol) products. NutraLife BioSciences’ brand portfolio consists of NutraHempCBD, PCR Pure, and HerbalShield.

For the years 2017 and 2018, NutraLife BioSciences generated revenues of roughly $1,790,000 and $3,770,00. Its private label business represented 91 percent and 99 percent of the Company’s revenues in 2017 and 2018. CBD products represented 67 percent of its private label sales in 2018.

Last week, Omni Medical Services and NutraLife BioSciences announced NutraLife to manufacture and provide finished CBD products for Omni’s new line of Omni CBD Solutions. Omni is a Michigan based physician-owned PLLC. It has eight years’ experience in providing medical cannabis evaluations to greater than 30,000 patients. Omni presently has clinic locations in five States including Michigan, Ohio, Illinois, Oklahoma and Florida.

In addition, last week, NutraLife Biosciences announced it has launched a new line of phytocannabinoid-rich (PCR) skincare and nutraceutical products under its in-house brand PCR Pure. NutraLife's new skincare line will debut with a facial gel cleanser, a daytime face cream, a nighttime face cream, as well as an eye cream. The Company states that all of the PCR Pure skincare products are formulated using effective, naturally derived ingredients, which nourish and rejuvenate the skin, and contain different natural plant extracts, including the hemp plant. All of PCR Pure’s products are free of parabens, sulfates, sulfites and suitable for daily use.

NutraLife BioSciences, Inc. (NLBS), closed Monday's trading session at $0.10, up 0.250627%, on 1,500 volume with 2 trades. The average volume for the last 3 months is 28,385 and the stock's 52-week low/high is $0.071099996/$0.300000011.

chart

Precision Optics Corporation, Inc. (PEYE)

Zacks, Hotstocked, Aim High Profits, Market Screener, AI Stock Finder, Wallet Investor, Simply Wall St, 4-Traders, OTC Dynamics, GlobeNewswire, PR Newswire, BioSpace, Research and Markets, TMXmoney, TradingView, Stockopedia, Investing.com and Dividend.com reported previously on Precision Optics Corporation, Inc. (PEYE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components. The Company provides state-of -the-art optics and optical systems for medical, biomedical, as well as industrial applications. Its inventive medical instrumentation line includes state-of-the-art endoscopes and endocouplers, and custom illumination and imaging products for use in minimally invasive surgical procedures. Precision Optics is headquartered in Gardner, Massachusetts.

The Company’s expertise is providing lenses to sizes as small as 0.2mm in diameter utilizing its proprietary Microprecision™ technology with the quality of ground lenses approaching the cost of gradient index (GRIN) lenses. Precision Optics can design, prototype, and manufacture, under one roof, optical systems and components for imaging of the body's smallest compartments and tissues.

Precision Optics has also mastered the advanced techniques needed to manufacture custom designed prisms. With tolerances to .01mm, it can produce a broad array of prisms to meet clients exacting requirements.

The Company also provides optical components, optical system design and production of diverse lens and prism products for the defense industry and aerospace industry. As a critical vendor, Precision Optics can assist a client’s optics development efforts from system design through volume optics fabrication and manufacturing.

Precision Optics has been contract manufacturing OEM (original equipment manufacturer) optics components and assemblies for greater than 30 years. The Company’s micro optical, micro mechanical, and electro optical assembly services use Precision’s specialized techniques, tools and fixtures to assemble components in the range of 1 millimeter and smaller. Precision fabricates and assembles components, sub-assemblies, and complete endoscopic instruments.

Last month, Precision Optics announced operating results on an unaudited basis for its Q1 Fiscal Year (FY) ended September 30, 2019. Revenue for Q1 was $2.5 million versus $1.6 million in the same quarter of the prior FY. This represents an increase of 61 percent driven chiefly by Ross Optical operating as a division of Precision Optics.

The Company had Gross Margins of 39 percent versus 30 percent in the same quarter of the prior year, and sequentially improved for the third consecutive quarter. Net Loss of $86,000 during the quarter included $122,000 of stock-based compensation and service fees. Precision Optics' Chief Executive Officer, Dr. Joseph Forkey, said, "The first quarter financial results highlight the positive impact of our evolving capabilities, which now include Ross Optical, resulting in a year-over-year revenue increase of 61 percent and positive operating cash flow.”

Precision Optics Corporation, Inc. (PEYE), closed Monday's trading session at $1.45, off by 3.3333%, on 5,807 volume with 8 trades. The average volume for the last 3 months is 6,812 and the stock's 52-week low/high is $1.04999995/$1.84000003.

chart

CannaPowder, Inc. (CAPD)

TeleTrader, Street Insider, Last10k, Wallet Investor, Market Screener, InvestorsHub, Stockhouse and Simply Wall St reported beforehand on CannaPowder, Inc. (CAPD), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

CannaPowder, Inc. is developing innovative nanometric cannabis powders. These are to enable cannabis users, whether for recreational or medicinal purposes, to more efficiently interact with the endocannabinoid mechanism. Nanometric powder is a pioneering drug delivery mechanism that is highly efficient. The Company previously went by the name Smart Energy Solutions, Inc. It changed its name to CannaPowder, Inc. in December of 2017. Established in 1999, CannaPowder has its head office in Tel Aviv, Israel.

Nanometric powders have considerable advantages over non-nanometric powders and plant oils. These include effective production processes and acceptable dosage forms, decreased dosage requirement, improved absorption, bioavailability and efficacy, and relatively long shelf life. Nanometric powders are already being used for other plants by some generic pharmaceutical companies, with different FDA (Food and Drug Administration) approved drugs, and by other industries such as cosmetics, beauty products and others.

The technology that is the foundation CannaPowder’s delivery system was developed at The Hebrew University of Jerusalem, an international leader in academic research and development of medical cannabis, under the leadership of Dr. Shlomo Magdassi, Professor of Chemistry at the Center for Nanoscience and Nanotechnology.

CannaPowder, having verified the technology, entered into an exclusive global license for the process with Yissum Research and Development Company. This is the technology transfer arm of The Hebrew University of Jerusalem.

The Company has engaged Professor Magdassi to continue oversight of its work to commercialize the technology on an industrial scale. In addition, CannaPowder entered into an agreement with Univo Pharmaceutical Ltd., to process cannabis on its behalf. Univo has one of the very few processing licenses issued in Israel.

The technology involves the use of a Nanometric powder formulation consisting of a cannabinoid oil and other materials that are dispersed in water controlled by a number of repeatable parameters. The oil concentration can be increased or decreased in the process and can include permeation enhancers for increasing bioavailability. Moreover, it can be formulated in different pharmaceutical delivery systems including capsules, tablets, creams, as well as aqueous dispersions.

CannaPowder, Inc. (CAPD), closed Monday's trading session at $1.18, up 96.6667%, on 100 volume with 1 trade. The average volume for the last 3 months is 53 and the stock's 52-week low/high is $0.50999999/$3.00.

chart

Peekaboo Beans, Inc. (PBBSF)

Small Cap Power, Pinnacle Digest, Morningstar, Barchart, Investorx, Investors Hangout, Dividend Investor, Trading View, Stockwatch, OTC Markets, Wallet Investor, and Stockhouse reported earlier on Peekaboo Beans, Inc. (PBBSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Peekaboo Beans, Inc. designs, manufactures, and sells children playwear apparel in the United States and Canada. The Company focuses on ethically produced, environmentally responsible clothes that are intentionally designed to inspire play. It engages sellers by way of social platforms, including Instagram and Facebook, and also online retailers, to maximize revenue and build brand loyalty. Peekaboo Beans distributes its products via a direct-sales channel of independent sales representatives or stylists; and online. Peekaboo Beans has its corporate headquarters in Vancouver, British Columbia.

The Company sells dresses and tunics, tees and tanks, hoodies, leggings and pants, skirts and shorts, and jackets and coats for girls. It also sells bean playsuits, tees and tanks, jackets and coats, and leggings and pants. Furthermore, Peekaboo Beans sells tees and tanks, hoodies, pants and shorts, jackets and coats and underwear for boys. The Company also provides accessories, including backpacks, lunch bags, snack bags, water bottles, as well as baby accessories.

Peekaboo Beans styles are high-quality oeko-tex standard 100. This enables parents to make meaningful choices with their money by purchasing products that last longer and are passed along from child to child. As a result, this decreases wasteful spending. The Company produces its products to ensure sustainability. Its intention is to keep its clothing out of landfills for as long as possible, and as such its clothes are made to be durable.

Recently, Peekaboo Beans announced that Ms. Tamara Mimran, Merchandise Director of the Mimran Group, Inc., has been appointed to the Board of Directors of Peekaboo Beans. Ms. Mimran (together with her father and brother) manages more than ten different licenses internationally for the Alfred Sung brand.

Traci Costa, Founder and Chief Executive Officer of Peekaboo Beans, said, "We are very excited to welcome Tamara to the team. The Mimran family has an iconic legacy in Canadian fashion and Tamara's experience with developing brands internationally will be of great use to us, as we continue to expand our reach to loyal customers all across North America."

Peekaboo Beans, Inc. (PBBSF), closed Monday's trading session at $0.035, up 38.8889%, on 35,040 volume with 4 trades. The average volume for the last 3 months is 2,415 and the stock's 52-week low/high is $0.0136/$0.171000003.

chart

Lamperd Less Lethal, Inc. (LLLI)

Silicon Investor, Penny Stock Tweets, Investor Village, Equity Clock, Front Page Stocks, Last10k, and Stockopedia reported earlier on Lamperd Less Lethal, Inc. (LLLI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lamperd Less Lethal, Inc. designs, develops, manufactures, and sells civil and military defense equipment globally. The Company is an innovation leader and manufacturer of advanced security solutions for law enforcement, military and security agencies around the world. In addition, Lamperd offers advisory services and hands-on training classes run by highly accredited instructors. Lamperd Less Lethal is based in Sarnia, Ontario. The Company lists on the OTC Markets.

The Company sells more than 300 different products. These include small and large caliber projectile guns, flash-bang devices, pepper spray devices, 37mm & 40mm launching systems, and interlocking riot shields. Lamperd provides less lethal solutions to keep situations under control.

Lamperd Less Lethal offers a premier range of force training products and aids. The design of each is to maximize the training experience and bring realism to the process. Lamperd offers Training Aids, Law Enforcement Aids, as well as Shield Systems. The design of Lamperd Shields are to augment unit strength and ability via the innovative interlocking system incorporated into each shield.

Lamperd’s Extraction Shield is specifically designed for police officers or other emergency personnel who must deal with violent or unstable persons, including accident victims. This device is ideally sized and shaped to prevent broken ribs and other common injuries or bodily fluid contamination while transferring such persons to and from police cars, ambulances or other tight spaces.

Regarding Less Lethal Munitions, the Company offers 20 gauge, 12 gauge, 9 mm, 50 cal, 37- 40 mm. The design of all munitions are to fit standard issue magazines and standard weaponry, including pistols, rifles, shotguns, and launchers.

Concerning Less Lethal Solutions, Lamperd created a first-rate line of Less Lethal firearms/delivery systems and munitions ranging from 9mm to 50 caliber and impact rounds from 37 to 40 MM. The Company has its Defender I. It is a five shot, compact, lightweight hand held revolver delivering 20-Gauge incapacitating projectiles. Defender I is the only Less Lethal Delivery System that allows officers Instant Round Identification in critical situations.

Lamperd Less Lethal also has its Defender II. It is a shoulder fired, 20 Gauge Less Lethal delivery system. It operates on the time tested 5 round revolver action. The gun has an 18 ¾ inch barrel that is very accurate. It serves it very well for long distant shots for public order. Defender II is compact enough to be deployed in Close Quarter Battle situations.

This past April, Lamperd Less Lethal announced that it received a signed purchase order for guns and ammunition from an important new international police services customer. The value of the initial order for Lamperd products is totaled at $172,000 USD. This represents the largest international order that Lamperd has received to date (as of April 2, 2019).

Recently, Lamperd Less Lethal announced that it welcomed its latest distribution partner that will represent the full Lamperd product line. This new partner has wide-ranging experience in the security products field and excellent established client base contacts. LTL Global, LLC, headquartered in Southern Florida, offers advanced less than lethal security options globally. It has been manufacturing and selling its own line of 37mm launcher products for many years.

Starting immediately, LTL Global is authorized to sell the full Lamperd Less Lethal product line to buyers in any part of the U.S. Furthermore, LTL Global will now have an exclusive arrangement to market the Lamperd Less Lethal line to buyers in Latin America, which is a territory where LTL Global has had substantial experience and many professional contacts in the law enforcement and military fields.

Lamperd Less Lethal, Inc. (LLLI), closed Monday's trading session at $0.0168, up 64.6736%, on 12,863 volume with 1 trade. The average volume for the last 3 months is 80,068 and the stock's 52-week low/high is $0.007499999/$0.020999999.

chart

Rainforest Resources, Inc. (RRIF)

Streetwise Reports, InvestorsHub, MarketWatch, OTC Markets, Stockhouse, and Investing News reported on Rainforest Resources, Inc. (RRIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rainforest Resources, Inc.’s mission is to protect the ecosystems of the rainforest to reduce the impact of global warming. Rainforest Resources operates in the forestry sector. As part of its dedication to prevent global warming, the Company is making the best of efforts to preserve the rainforest, the initial phase being the “Huamboya Forest” Morona Santiago – Ecuador. At Huamboya, millenary trees and endemic species of the Amazon, terrestrial, aquatic, as well as aerial are found. Rainforest Resources has its U.S. office in Anna Maria, Florida.

The Company, in its dedication to ease global warming, commits all its efforts and economic support for the conservation of the humid forest. Furthermore, it produces carbon credit certificates and develops and exports natural spring water.

Rainforest Resources’ positions are in tropical rain forests, land for reforestation, and above all clean air. The Company’s vision is to sustain forestry and to live in harmony with forestry in itself.

Rainforest Resources is interested in conserving the Huamboya ecosystem. Huamboya presents a Humid Tropical Megathermal climate. The forest is covered by native forest without human intervention.

The Huamboya forest has about 586 endemic plant species of which 45 percent are orchids. The forest has a rich diversity of animal life. This includes 343 species of birds, 100 species of mammals, and more than 500 species of vertebrates.

Recently, Rainforest Resources announced, by way of its subsidiary Rain Forest Enterprises SA, that it purchased from Latitude Aerospace Solutions (LAS) a state of the art Drone model VTOL. When fitted with remote sensors, the Drone can detect the effect of greenhouse gases in a given area and provide data on CO2 and Oxygen levels. This is important information used in the computation for the issuance of Verified Emission Reductions (VERs)/Certified Emission Reductions (CERs).

The initial use of the Drone will be in the evaluation of Rainforest Resources’ rain forest properties in Ecuador to produce Verified Carbon Credit Certificates. Subsequently, it is the Company’s intention to provide the Drone services to other entities involved in the ecological preservation of the rainforests in Ecuador on a cost-plus basis. This will provide additional income to Rainforest Resources.

Rainforest Resources, Inc. (RRIF), closed Monday's trading session at $4.24, up 99.061%, on 33,745 volume with 169 trades. The average volume for the last 3 months is 4,065 and the stock's 52-week low/high is $1.56009995/$7.5999999.

chart

AEON Global Health Corp. (AGHC)

Amigo Bulls, Stock Target Advisor, Stockopedia, Investors Hangout, Penny Stock Hub, Stockwatch, Simply Wall St, Zacks, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stockflare, and Dividend Investor reported on AEON Global Health Corp. (AGHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AEON Global Health Corp., together with its subsidiaries, provides a variety of clinical laboratory testing services in the United States. The Company provides diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, as well as Health Technology Applications. AEON formerly went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. in January 2018. OTCQB-listed, AEON Global Health has its corporate office in Gainesville, Georgia.

The Company is the fastest growing clinical lab and healthcare services organization in the United States. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results. AEON’s chief business focus is providing a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information.

AEON is an innovator in the genomic testing area. The Company has an extensive menu of genetic tests and a pipeline of additional molecular-based tests in development. It provides post contract customer support services. The design of AEON’s Telehealth Solutions is to improve outcomes and reduce hospital readmission through helping clinicians closely monitor patients with chronic illnesses. These include CHF, COPD and Diabetes.

Concerning Toxicology Testing, AEON Global Health provides accurate and fast quantitative testing of drug metabolite levels in urine and oral fluids. The Company’s testing covers more than 80 analytes and metabolites. Its HPLC-tandem mass spectrometry can analyze wider molecular weight and polarity ranges of analytes, providing better selectivity and sensitivity.

AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface. Inscrybe® enables physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or via electronic fax instead of transferring paper.

In May 2018, AEON Global Health announced it earned The Joint Commission’s Gold Seal of Approval® for Laboratory Services Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval is a symbol of quality, which reflects an organization’s commitment to providing safe and effective patient care.

AEON Global Health underwent a thorough onsite survey earlier in 2018. During the review, a Joint Commission expert surveyor evaluated compliance with laboratory standards related to a number of areas. This included document and process control, healthcare-associated conditions, risk reduction, as well as staff qualifications and competency. Additionally, the surveyor conducted onsite observations and interviews.

AEON Global Health Corp. (AGHC), closed Monday's trading session at $0.069, up 72.50%, on 31,005 volume with 6 trades. The average volume for the last 3 months is 9,292 and the stock's 52-week low/high is $0.026/$0.670000016.

chart

North America Frac Sand, Inc. (NAFS)

PennyStockProfessor,  SMS Penny Picks, DSR News,  eliteotc.com, Wall Street Beauties, WINNINGOTC,  BestDamnPennyStocks,  PennyPickAlerts,  TheNextBigTrade, Stock Commander, Fortune Stock Alerts, and  Penny Stock Hub reported earlier on North America Frac Sand, Inc. (NAFS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

North America Frac Sand, Inc. is a development stage company based in Saskatoon, Saskatchewan.  It owns renewable land leases with the right to extract frac sand from significant mineral deposits situated in the Province of Saskatchewan. The Company has 29,900 acres of leases and lease options, which are 30 kilometers east of Saskatoon. North America Frac Sand lists on the OTC Markets Group’s OTCQB.

North America Frac Sand acquired North America Frac Sand (CA) Ltd. and its acres of leases in 2015. In 2016, North America Frac Sand announced the completion of the due diligence obligatory preceding the decision to close on the acquisition of North America Frac Sand (CA) Ltd. (NAFS-CA).

Frac Sand is a proppant used in the oil & gas industry as part of the hydraulic fracturing process - a way to enhance flow to the wellhead. North America Frac Sand’s strategy is to achieve a major presence in the frac sand industry through developing a long term, high quality, and secure supply of frac sand for the oil & gas industry in Western Canada and the Northwestern United States.

  Frac sand must have definite characteristics. These include reaching certain levels of crush resistance, sphericity, and roundness. As a result, frac sand is a relatively rare commodity.

North America Frac Sand has established relationships with all the major well service companies. These include several large oil & gas companies. Additionally, the Company has government and municipality support.

North America Frac Sand’s short-term plan is to prove out the balance of its major resource. Its long-term plan is to begin shipments of frac sand as soon as possible.

In addition, the Company’s strategy is to develop and maximize the mineral deposit under its land and optioned leases. Its strategy is also to develop a long-term relationship with well service and oil & gas companies that center on quality service and product. Furthermore, North America Frac Sand’s strategy involves providing a year-round supply of frac sand to customers.

North America Frac Sand received its initial "Technical Report" addressing its Eagle Creek Property in Saskatchewan on May 25, 2017. The Technical Report encompasses exploration to date on a portion of the Company’s leased areas (roughly 12,100 hectares [29,900 acres]).

Recently, North America Frac Sand announced it has been in discussions with numerous Canadian publicly traded companies concerning its Eagle Ridge Property.

Mr. Joseph Kistler, North America Frac Sand President, said, "The Company has been involved with substantive discussions regarding the furtherance of the Eagle Ridge Frac Sand project and I am pleased to report that the interest has been extremely positive. It is my intention to partner with a group (in Canada near the Eagle Ridge project) that is capable to complete the drilling program so that the true value of the Company owned leases will be validated and bring value to the company's preferred and common shareholders. We plan on deciding in the very near future.”

North America Frac Sand, Inc. (NAFS), closed Monday's trading session at $0.015, up 100.00%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 30,292 and the stock's 52-week low/high is $0.0035/$0.034000001.

chart

Foothills Exploration, Inc. (FTXP)

MarketWired, OTC Markets, and InvestorsHub reported on Foothills Exploration, Inc. (FTXP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Foothills Exploration, Inc., through its wholly-owned subsidiary, Foothills Petroleum, Inc. (a Nevada corporation), is an early stage independent oil and gas exploration and production company. It involves in the acquisition and development of oil and gas properties in the Rockies. The Company’s goal is to acquire dislocated and underdeveloped oil and gas assets and maximize those assets. Foothills Exploration is headquartered in Denver, Colorado.

The Company’s strategy is to build a balanced portfolio of E&P assets through concentrating on acquiring producing and developmental properties in the Rockies and focusing on the generation of high-impact oil and gas exploration projects. Foothills Exploration’s goal is to build a land bank of more than 200,000 acres of proven, probable, and prospective reserves.

Currently, Foothills Exploration holds 41,181 acres in the Greater Green River Basin in Wyoming. Its Springs Prospect consists of 38,120 contiguous acres. This is a multiple objective oil resource play in the Greater Green River Basin.

Moreover, the Company has a 35 percent Working Interest (WI) in the Ladysmith Anticline prospect. This prospect is in Fremont County, Wyoming. Ladysmith Anticline in entirety amounts to 3,061 acres. Its location is between the Great Divide/Greater Green River Basin and the Wind River Basin.

Foothills also has its PawPaw Project. The Pawpaw project is a 3-D seismic defined prospect. It covers 4,467 acres and is a direct analog to the highly productive Tensleep Formation “Enigma” Field positioned two miles south.

The Company also has its Ironwood Project. The Ironwood Project is a 6,115-acre up dip field extension play. The adjacent “Cotton Creek” Field produced about 67 million barrels of oil (MMBO) and 68 billion cubic feet of gas (BCFG), chiefly from the Phosphoria Formation.

Foothills Exploration announced in February 2017 that since acquiring Tiger Energy Partners International on December 30, 2016, Foothills has successfully reworked two wells in its Duck Creek project obtaining production from the Green River formation.

Regarding the Duck Creek Area – Natural Buttes Field, Foothills Exploration plans to re-enter two wells in September in the Duck Creek region situated in Uintah County, Utah, in the Natural Buttes field. The Duck Creek wells recently had a third-party engineering report completed. The Report calculated a total PV-10 value of $707,000 of Proved Developed Producing and Proved Developed Non-Producing reserves.

Concerning the Altamont- Bluebell and Brundage Canyon areas, a third-party reserve report was conducted on certain properties, which were acquired via the Tiger Energy Partners International acquisition. According to this Report, the properties have roughly 5.4 million barrels of Proved Undeveloped Reserves. The well depths range from 5,500 feet in the Brundage Canyon area to roughly 18,000 feet in the Altamont-Bluebell area.

Foothills Exploration, Inc. (FTXP), closed Monday's trading session at $0.007, up 100.00%, on 11,115,427 volume with 167 trades. The average volume for the last 3 months is 1,773,771 and the stock's 52-week low/high is $0.0017/$0.680000007.

chart

The QualityStocks Company Corner

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Business-to-business pharmacy services supplier Trxade Group Inc. (OTCQB: TRXD), a health care industry influencer passionate about sustaining independent, community-based drug store operations, will round out a year of continued expansion by presenting its corporate operations to attendees at this year’s LD Micro Main Event microcap financing opportunity.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed Monday's trading session at $1.40, up 7.6923%, on 3,442 volume with 6 trades. The average volume for the last 3 months is 3,251 and the stock's 52-week low/high is $0.230000004/$1.60000002.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs Inc. (NASDAQ: SGLB), a leading producer of quality-assurance software for the commercial 3D-printing industry, demonstrated the latest version of its proprietary technology PrintRite3D(R) in collaboration with Materialise NV at the Formnext 2019 conference held in Frankfurt, Germany, on November 19-22.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Monday's trading session at $1.05, up 2.9412%, on 47,238 volume with 112 trades. The average volume for the last 3 months is 189,000 and the stock's 52-week low/high is $0.451099991/$2.46000003.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings Inc. (OTC: MCTC) was featured today in a publication from HempWireNews, examining how, on Wednesday, the Brazilian pharmaceutical regulator, Anvisa, approved the roll-out of medicinal marijuana-based products. However, in a separate vote, Anvisa vetoed a proposal seeking to legalize the cultivation of domestic medical marijuana. But, one company was authorized to cultivate industrial hemp by a judge.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Monday's trading session at $0.49, up 2.0833%, on 28,638 volume with 14 trades. The average volume for the last 3 months is 13,776 and the stock's 52-week low/high is $0.075000002/$3.00.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced its plans to present at the 12th Annual LD Micro Main Event taking place at the Luxe Sunset in Bel-Air, California from December 10-12, 2019. To view the full press release, visit http://cnw.fm/c2dMM. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. On Tuesday, the residents of New Zealand got a peek at the contents of a draft proposal on marijuana legalization that will be subject to a voter’s decision during the 2020 ballot.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Monday's trading session at $0.21, up 5.00%, on 9,196 volume with 13 trades. The average volume for the last 3 months is 45,728 and the stock's 52-week low/high is $0.165000006/$0.654999971.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), an oil sands mining and production company having a proprietary technology that extracts hydrocarbons without the use of water, today announced an update on oil production and the facility’s oil quality baseline. Among the updates, Petroteq reported that, since completion of automation on November 25, 2019, the facility has produced an average 80 barrels of sales oil in 12-hour process shifts - a total of 10 days of the 14 day period, as well as an average of 150 barrels of sales oil in 12-hour process shifts over the last two days. To view the full press release, visit http://nnw.fm/F4Cax.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Monday's trading session at $0.1422, up 0.140845%, on 382,053 volume with 71 trades. The average volume for the last 3 months is 294,970 and the stock's 52-week low/high is $0.112099997/$0.51999998.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders Inc. (OTC: NBDR) was featured today in a publication from HempWireNews, examining how on Wednesday, the Brazilian pharmaceutical regulator, Anvisa, approved the roll-out of medicinal marijuana-based products. However, in a separate vote, Anvisa vetoed a proposal seeking to legalize the cultivation of domestic medical marijuana. But, one company was authorized to cultivate industrial hemp by a judge.

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Monday's trading session at $0.024, up 33.3333%, on 99,000 volume with 3 trades. The average volume for the last 3 months is 59,182 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

chart

Neutra Corp. (OTCQB: NTRR)

The QualityStocks Daily Newsletter would like to spotlight Neutra Corp. (NTRR).

Neutra Corp. (OTC: NTRR) today announced its continued moves toward growth and expansion. According to the update, the company has entered an important letter of intent (“LOI”) with Power Auto Corporation to acquire a complex consisting of buildings and land that would allow Neutra to achieve its vertical integration plans. To view the full press release, visit http://cnw.fm/XbB47.

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

  • VIVIS – Neutra continues to expand its market presence in the rapidly growing hemp-derived CBD market and recently acquired VIVIS, an emerging retail brand of hemp-based health and nutritional products. VIVIS’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With VIVIS as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
  • J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

  • Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
  • ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

Neutra Corp. (OTCQB: NTRR), closed Monday's trading session at $0.0009, up 12.50%, on 81,865,996 volume with 92 trades. The average volume for the last 3 months is 25,592,911 and the stock's 52-week low/high is $0.0006/$0.063900001.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced updates on the commercialization of its CancerQuest 2020 initiative. To view the full press release, visit http://nnw.fm/5d3BI

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Monday's trading session at $3.00, off by 0.332226%, on 24,054 volume with 157 trades. The average volume for the last 3 months is 41,892 and the stock's 52-week low/high is $2.3499999/$8.50.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) was featured today in the 420 with CNW by CannabisNewsWire. On Tuesday, the residents of New Zealand got a peek at the contents of a draft proposal on marijuana legalization that will be subject to a voter’s decision during the 2020 ballot.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Monday's trading session at $0.96, up 0.491992%, on 146,794 volume with 238 trades. The average volume for the last 3 months is 143,532 and the stock's 52-week low/high is $0.779999971/$4.7800002.

Recent News

chart

OriginClear (OTC: OCLN)

The QualityStocks Daily Newsletter would like to spotlight OriginClear (OTC: OCLN).

OriginClear Inc. (OTC: OCLN) and its Spanish partner, Depuporc®, recently showcased the company’s manure-treatment pilot system, which fully integrates OriginClear’s Electro Water Separation™ (EWS) and Advanced Oxidation™ (AOx) technologies (http://nnw.fm/o68Ts).

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.


Industrial Pretreatment Waste Water Treatment Plant (WWTP) designed by Daniel M. Early, using reinforced thermoplastic modules.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

In just 10 years, the global water services market has doubled into a trillion-dollar industry, driven by improper sanitation and water scarcity. Only 20 percent of all sewage and only 30 percent of all industrial waste are ever treated. Additionally, water leakage results in the loss of 35 percent of all clean water across the planet; reducing that percentage by half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

The statistics demonstrate that we can no longer rely on the efficiencies of giant, centralized water utilities to meet these challenges. An increasing number of businesses are starting to take notice, instead conducting their own water treatment and recycling. Whether by choice or out of necessity, those businesses that do invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of the public’s eye and with OriginClear’s help, a growing number of self-reliant businesses are building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which represent $22 trillion of assets under management around the world, specifically note the key indicator of how well corporations manage their water.


10,000 Gallon per Day Industrial Membrane Bioreactor Waste Water Treatment Plant designed by Daniel M. Early, PE, using long-lived Structural Reinforced ThermoPlastic (SRTP)

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

 

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

OriginClear (OCLN), closed Monday's trading session at $0.38, off by 5.00%, on 52,716 volume with 39 trades. The average volume for the last 3 months is 30,941 and the stock's 52-week low/high is $0.100000001/$5.80000019.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC).

Saskatchewan, Canada-based HTC Extraction Systems (TSX.V: HTC) saw its revenues grow by more than 2.5 times in year-over-year third-quarter financial results that were reported recently on the heels of news the proprietary extraction systems innovator is expanding its fledgling cannabinoid refining operations from Canada to the U.S. market in California.

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (TSX.V: HTC), closed Monday's trading session at $0.205, off by 14.5833%, on 159,750 volume with 24 trades. The average volume for the last 3 months is 128,967 and the stock's 52-week low/high is $0.079999998/$1.24.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announced the resignation of Donald J. Steinberg as chairman of the board, chief executive officer and treasurer. According to the update, the Company’s new focus will be to enter strategic acquisitions with various operational cannabis and hemp companies that are distressed in order to expand its vertical model, as well as expand its hempSMART(TM) branded product lines and marketing channels and launch other CBD brands using a direct-to-consumer sales approach. To view the full press release, visit http://cnw.fm/Z6Xp3. Also today, the company was highlighted in a publication from CBDWire, examining how interest in hemp extract cannabidiol (CBD) for the past few years has steadily been on the rise, with CBD growing from an obscure product into an industry worth billions. Packed with potent medicinal properties, the compound is said to cure a never-ending list of ailments ranging from insomnia, anxiety to high blood pressure.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Monday's trading session at $0.10, off by 9.0909%, on 1,487,300 volume with 234 trades. The average volume for the last 3 months is 358,509 and the stock's 52-week low/high is $0.023/$2.10599994.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) was highlighted today in a publication from Stock Market Press, examining how the industry is seeing sharply higher growth in solar installations in 2020 and beyond, as many companies have grown in solar by takeover. Others are jockeying for market position in solar by re-strategizing growth plans.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.01, off by 4.7619%, on 2,058,514 volume with 71 trades. The average volume for the last 3 months is 2,717,968 and the stock's 52-week low/high is $0.009999999/$0.028799999.

Recent News

chart

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

Heeding expert forecasts, fintech holding company Xalles Holdings Inc. (OTC: XALL) is banking on the bullish cryptocurrency global trend as it takes steps to perfect its distribution of automated crypto trading solutions and make cryptocurrency trading more accessible. Since decentralized systems are gaining in popularity given their unique advantage of not being directly impacted by government and bank policies, a growing number of major financial institutions have started working on their own cryptocurrency strategies.

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
All current subsidiaries are wholly owned

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Advancements in 2019

  • Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
  • Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
  • Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.

“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”

– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)

Xalles Holdings Inc. (OTC: XALL), closed Monday's trading session at $0.0018, off by 25.00%, on 6,055,370 volume with 29 trades. The average volume for the last 3 months is 1,246,991 and the stock's 52-week low/high is $0.0013/$0.021029999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.